Find your Insights

Make better informed strategic decisions with accurate, interlinked

narratives about drug development

Advanced Search Structure Search

What's New

Patents Is Here

Today we launched a new subscription content set that integrates with AdisInsight Drugs to provide...

Patents Is Here

Today we launched a new subscription content set that integrates with AdisInsight Drugs to provide additional information about global patents and regional exclusivities in a drug patent profile to make it easy for all users to search, understand, and incorporate patent information in their analysis.

GDPR Compliant

The General Data Protection Regulation (GDPR) goes into effect on May 25, 2018. This regulation...

GDPR Compliant

The General Data Protection Regulation (GDPR) goes into effect on May 25, 2018. This regulation harmonizes privacy and data protection laws within the European Economic Area. It expands on an individual’s ability to access and control the personal data that we collect from them on AdisInsight.

Updated Financial Forecasts

We have updated the Credit Suisse financial forecasts to show projections out to 2025.

Updated Financial Forecasts

We have updated the Credit Suisse financial forecasts to show projections out to 2025.

New secure https communication

We have moved to https communication to protect the privacy and integrity of the data exchanged...

New secure https communication

We have moved to https communication to protect the privacy and integrity of the data exchanged between our users and the AdisInsight platform. Https protects against threats through bidirectional encryption of communication to protect against eavesdropping and tampering of the communication. In practice, this provides a reasonable assurance that one is communicating with AdisInsight, as opposed to an impostor.

New advanced search look and feel

The advanced search re-design is complete. Using cues from the old R& D Insight search the new...

New advanced search look and feel

The advanced search re-design is complete. Using cues from the old R& D Insight search the new advanced search is easier and more intuitive. It also incorporates filter facets previously only available on the search results page. This allows use of more content specific search terms and better supports editing searches that include filter facets from the search results page.

Biomarker table in Drug profiles enhanced with information on Trials

You can now view the number of Trials associated with a Biomarker straightaway in the Biomarker...

Biomarker table in Drug profiles enhanced with information on Trials

You can now view the number of Trials associated with a Biomarker straightaway in the Biomarker table for Drugs. Clicking on the Trials count will take you directly to the list of Trials under the Trials tab.

  • 0
  • 1

Drugs in Development

How many drugs are currently in active development worldwide?

MarketedRegulatoryPhase IIIPhase IIPhase IOther ClinicalPhasePreclinical3,0951,1632,9226,9971,956
bucketNameNumber of Drugs
Marketed3,095
Regulatory472
Phase III1,163
Phase II2,922
Phase I1,956
Other Clinical Phase275
Preclinical6,997

Clinical Trials Landscape

How many clinical trials are currently underway globally?

PlanningNot YetRecruitingRecruitingActive3,6013,8638,71919,784
bucketNameNumber of Drugs
Planning3,601
Not Yet Recruiting3,863
Recruiting19,784
Active8,719

Drug Development Locations

Where is drug development currently happening around the world?

Number of Drugs07,50015,00022,500USAUnited KingdomJapanGermanyCanadaFranceScandinaviaBeneluxAustraliaChina
bucketNameNumber of Drugs
USA24,073
United Kingdom5,332
Japan5,165
Germany4,116
Canada3,829
France3,132
Scandinavia2,986
Benelux2,931
Australia2,704
China2,648

Drug Development Organizations

What are the top-10 drug development organizations worldwide?

Number of Drugs05001,0001,500PfizerNational Institu…GlaxoSmithKlineMerck & CoRocheNovartisAstraZenecaBristol-Myers…Johnson & Joh…Eli Lilly
bucketNameNumber of Drugs
Pfizer1,657
National Institutes of Health (USA)1,407
GlaxoSmithKline1,309
Merck & Co1,157
Roche1,151
Novartis1,029
AstraZeneca914
Bristol-Myers Squibb818
Johnson & Johnson813
Eli Lilly695

Adverse Events

What are the top-10 most commonly published Individual Case Safety Reports (ICSRs) globally

Number of Safety ReportsNeurological disordersCardiovascular disordersSkin disordersCNS disordersDigestive system disorders15,00020,00025,00030,00035,000
bucketNameNumber of Safety Reports
Neurological disorders32,190
Pathological conditions, signs and symptoms31,372
Cardiovascular disorders26,388
Skin and connective tissue diseases21,767
Skin disorders21,765
Haematological disorders21,608
CNS disorders19,938
Immunological disorders19,438
Digestive system disorders18,873
Vascular disorders17,453

Ask the Expert

Do you need help ? Please contact one of our AdisInsight experts

We aim to get back to you with personalized answer within 24 hours

Events across the world

September 2018

So far, there is no event in this month

Insights into AdisInsight

Short videos to see how AdisInsight can help your organization

A database for drug development and research, disease treatment and decision making, based on trusted, scientifically sound data.

See how the AdisInsight platform can help you to work more strategically to advance research, get published and win funding.

The case study of a lead investigator at a university drug discovery center as they use AdisInsight to find the best path from investigation to investment.

Una base de datos para la investigación y el desarrollo farmacológicos, el tratamiento de enfermedades y la toma de decisiones, basada en datos confiables con sustento científico.

医薬品研究開発における、確かな科学情報に基づいた戦略的な意思決定を支援するデータベース